JP2013519367A5 - - Google Patents

Info

Publication number

JP2013519367A5

JP2013519367A5 JP2012552459A JP2012552459A JP2013519367A5 JP 2013519367 A5 JP2013519367 A5 JP 2013519367A5 JP 2012552459 A JP2012552459 A JP 2012552459A JP 2012552459 A JP2012552459 A JP 2012552459A JP 2013519367 A5 JP2013519367 A5 JP 2013519367A5

Authority

JP

Japan

Prior art keywords

antibody

sequence

amino acid

seq

acid sequence

Prior art date

2011-02-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 125000003275 alpha amino acid group Chemical group 0.000 claims 105
• 102000012000 CXCR4 Receptors Human genes 0.000 claims 52
• 108010061299 CXCR4 Receptors Proteins 0.000 claims 52
• 102100024952 Protein CBFA2T1 Human genes 0.000 claims 27
• 239000000203 mixture Substances 0.000 claims 24
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims 21
• 210000004027 cell Anatomy 0.000 claims 19
• 201000010099 disease Diseases 0.000 claims 18
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 18
• 238000000034 method Methods 0.000 claims 18
• 150000001413 amino acids Chemical class 0.000 claims 13
• 238000006467 substitution reaction Methods 0.000 claims 11
• 241001465754 Metazoa Species 0.000 claims 9
• 230000001225 therapeutic effect Effects 0.000 claims 9
• 238000011282 treatment Methods 0.000 claims 9
• 206010028980 Neoplasm Diseases 0.000 claims 8
• 230000005764 inhibitory process Effects 0.000 claims 8
• 239000003814 drug Substances 0.000 claims 7
• 230000014509 gene expression Effects 0.000 claims 7
• 229940124597 therapeutic agent Drugs 0.000 claims 7
• 239000000427 antigen Substances 0.000 claims 6
• 201000011510 cancer Diseases 0.000 claims 6
• 229940127121 immunoconjugate Drugs 0.000 claims 6
• 239000003446 ligand Substances 0.000 claims 6
• 150000007523 nucleic acids Chemical class 0.000 claims 6
• 102000039446 nucleic acids Human genes 0.000 claims 6
• 108020004707 nucleic acids Proteins 0.000 claims 6
• 239000013604 expression vector Substances 0.000 claims 5
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
• 102000036639 antigens Human genes 0.000 claims 4
• 108091007433 antigens Proteins 0.000 claims 4
• 239000012634 fragment Substances 0.000 claims 4
• 230000006907 apoptotic process Effects 0.000 claims 3
• 239000003795 chemical substances by application Substances 0.000 claims 3
• 230000000694 effects Effects 0.000 claims 3
• 230000006698 induction Effects 0.000 claims 3
• 239000003112 inhibitor Substances 0.000 claims 3
• 230000009545 invasion Effects 0.000 claims 3
• 230000001404 mediated effect Effects 0.000 claims 3
• 239000002773 nucleotide Substances 0.000 claims 3
• 125000003729 nucleotide group Chemical group 0.000 claims 3
• 210000000056 organ Anatomy 0.000 claims 3
• 208000023275 Autoimmune disease Diseases 0.000 claims 2
• 208000031886 HIV Infections Diseases 0.000 claims 2
• 208000037357 HIV infectious disease Diseases 0.000 claims 2
• 206010061218 Inflammation Diseases 0.000 claims 2
• 208000036142 Viral infection Diseases 0.000 claims 2
• 241000700605 Viruses Species 0.000 claims 2
• 230000002159 abnormal effect Effects 0.000 claims 2
• 230000033115 angiogenesis Effects 0.000 claims 2
• 239000002246 antineoplastic agent Substances 0.000 claims 2
• 239000003443 antiviral agent Substances 0.000 claims 2
• 230000015572 biosynthetic process Effects 0.000 claims 2
• 210000001185 bone marrow Anatomy 0.000 claims 2
• 229940127089 cytotoxic agent Drugs 0.000 claims 2
• 238000003745 diagnosis Methods 0.000 claims 2
• 239000000032 diagnostic agent Substances 0.000 claims 2
• 229940039227 diagnostic agent Drugs 0.000 claims 2
• 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 2
• 210000000987 immune system Anatomy 0.000 claims 2
• 208000026278 immune system disease Diseases 0.000 claims 2
• 238000001727 in vivo Methods 0.000 claims 2
• 230000004054 inflammatory process Effects 0.000 claims 2
• 208000037819 metastatic cancer Diseases 0.000 claims 2
• 208000011575 metastatic malignant neoplasm Diseases 0.000 claims 2
• 230000005012 migration Effects 0.000 claims 2
• 238000013508 migration Methods 0.000 claims 2
• 239000002777 nucleoside Substances 0.000 claims 2
• 230000002018 overexpression Effects 0.000 claims 2
• 230000035755 proliferation Effects 0.000 claims 2
• 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
• 210000000130 stem cell Anatomy 0.000 claims 2
• 230000009385 viral infection Effects 0.000 claims 2
• 229940121819 ATPase inhibitor Drugs 0.000 claims 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims 1
• 102000019034 Chemokines Human genes 0.000 claims 1
• 108010012236 Chemokines Proteins 0.000 claims 1
• 102000004127 Cytokines Human genes 0.000 claims 1
• 108090000695 Cytokines Proteins 0.000 claims 1
• 102100032530 Glypican-3 Human genes 0.000 claims 1
• 101001014668 Homo sapiens Glypican-3 Proteins 0.000 claims 1
• 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
• 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
• 102100034343 Integrase Human genes 0.000 claims 1
• 206010027476 Metastases Diseases 0.000 claims 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims 1
• 206010070834 Sensitisation Diseases 0.000 claims 1
• 208000003874 Simpson-Golabi-Behmel syndrome Diseases 0.000 claims 1
• 108010003723 Single-Domain Antibodies Proteins 0.000 claims 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 1
• 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims 1
• 230000004913 activation Effects 0.000 claims 1
• 239000000362 adenosine triphosphatase inhibitor Substances 0.000 claims 1
• 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
• 239000002260 anti-inflammatory agent Substances 0.000 claims 1
• 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
• 230000000259 anti-tumor effect Effects 0.000 claims 1
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 claims 1
• 229910052791 calcium Inorganic materials 0.000 claims 1
• 239000011575 calcium Substances 0.000 claims 1
• 229910001424 calcium ion Inorganic materials 0.000 claims 1
• 230000036755 cellular response Effects 0.000 claims 1
• 239000002559 chemokine receptor antagonist Substances 0.000 claims 1
• 239000000701 coagulant Substances 0.000 claims 1
• 150000001875 compounds Chemical class 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 239000000430 cytokine receptor antagonist Substances 0.000 claims 1
• 239000002254 cytotoxic agent Substances 0.000 claims 1
• 231100000599 cytotoxic agent Toxicity 0.000 claims 1
• 239000000539 dimer Substances 0.000 claims 1
• 238000000375 direct analysis in real time Methods 0.000 claims 1
• 238000012063 dual-affinity re-targeting Methods 0.000 claims 1
• 230000002349 favourable effect Effects 0.000 claims 1
• 238000003384 imaging method Methods 0.000 claims 1
• 238000000338 in vitro Methods 0.000 claims 1
• 230000001939 inductive effect Effects 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 230000009401 metastasis Effects 0.000 claims 1
• 230000010807 negative regulation of binding Effects 0.000 claims 1
• 229940042402 non-nucleoside reverse transcriptase inhibitor Drugs 0.000 claims 1
• 239000002726 nonnucleoside reverse transcriptase inhibitor Substances 0.000 claims 1
• 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
• 125000003835 nucleoside group Chemical group 0.000 claims 1
• -1 other antibody Substances 0.000 claims 1
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
• 230000008569 process Effects 0.000 claims 1
• 230000005855 radiation Effects 0.000 claims 1
• 230000004044 response Effects 0.000 claims 1
• 230000008313 sensitization Effects 0.000 claims 1
• 230000019491 signal transduction Effects 0.000 claims 1
• 150000003431 steroids Chemical class 0.000 claims 1
• 238000002560 therapeutic procedure Methods 0.000 claims 1
• 210000004881 tumor cell Anatomy 0.000 claims 1